TrueShares Technology, AI & Deep Learning ETF (ARCA: LRNZ)

에 대한 최신 뉴스 TrueShares Technology, AI & Deep Learning ETF (ARCA:LRNZ)

Technology

Other

Healthcare

Consumer Cyclical

Communication Services

The Fund is an actively-managed exchange-traded fund (ETF) that pursues its investment objective by investing, under normal circumstances, at least 80 percentage of its net assets (plus any borrowings made for investment purposes) in the common stock of technology, artificial intelligence and deep learning companies. The Fund generally considers a company to be a technology, artificial intelligence and/or deep learning company if it derives 50 percentage or more of its revenues or profits from the development, advancement and/or use of technology, including artificial intelligence-and/or deep learning-related technologies, or if it has committed 50 percentage or more of its research and development-dedicated capital to the development, advancement and/or use of such technology, each measured at the time of investment

Nvidia Corp.

Samsara Inc, Class A

Crowdstrike Holdings Inc. Class A

Cloudflare Inc

Elastic N V

Advanced Micro Devices Inc.

ServiceNow Inc

Eli Lilly And Company

Datadog Inc

SentinelOne Inc

TrueMark Technology AI & Deep Learning ETF

Analyst Color

Equities

Large Cap

News

Reiteration

Analyst Ratings

Movers

Tech

Trading Ideas

LRNZ

골드만삭스 애널리스트 카쉬 랑간(Kash Rangan)은 몽고DB(NASDAQ:MDB)의 보이지AI(Voyage AI) 인수에 대해 월요일(24일) 매수 의견과 목표주가를 유지했다.

골드만삭스: 몽고DB의 &#39;보이지 AI&#39; 인수, 고급 기술과 인재로 AI 능력 향상

TrueShares Technology, AI & Deep Learning ETF

Wells Fargo analyst Larry Biegelsen maintains RxSight (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RXST#NASDAQ">RXST</a>) with a Equal-Weight and lowers the price target from $40 to $35.

Price Target

RXST

Wells Fargo Maintains Equal-Weight on RxSight, Lowers Price Target to $35

WIIM

USNA

Usana Health Sciences shares are trading higher after the company reported better-than-expected Q4 financial results.

Biotech

General

CNSP

CNS Pharmaceuticals Announces Plans For TPI 287 Clinical Program Launch By Year-End; Primary Data Analysis For Berubicin Expected In H1 2025

Safe &amp; Green Holdings Corp. (NASDAQ:<a href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) ("Safe &amp; Green Holdings" or the "Company"), a leading developer, designer, and fabricator of modular structures, today announced that it has entered into a non-binding Letter of Intent to acquire key assets and business operations of County Line Industrial, LLC, a respected industrial fabrication and modular manufacturing enterprise based in Bokchito, Oklahoma. The proposed transaction is subject to the execution of a definitive Asset Purchase Agreement and customary closing conditions.
County Line Industrial is recognized for its expertise in delivering custom-built modular components, precision welding, and on-site installation services. The company has built a reputation for operational excellence and reliability in meeting customer needs.
This acquisition is a key element of Safe &amp; Green's strategic growth plan. By integrating County Line Industrial's operational expertise with Safe &amp; Green's modular solutions business, the Company aims to create significant synergies that will streamline supply chains, improve profitability and accelerate time-to-market. The initiative also complements the innovative platforms of Olenox and Machfu.com, as highlighted in recent press releases, positioning the combined businesses to deliver sustainable, long-term value to investors.
Safe &amp; Green will also secure the continued service of essential personnel from County Line Industrial, including General Manager Carter Fields and other key team members, ensuring a smooth transition and the preservation of vital customer relationships.

SGBX

Safe & Green Holdings Announces Plan To Acquire Key Assets Of County Line Industrial; Aims For Synergistic Growth, Streamlined Operations, And Enhanced Modular Capabilities; Targeting H1 2025 Closing; Terms Not Disclosed

Stephens &amp; Co. analyst Charles Nabhan downgrades Flywire (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLYW#NASDAQ">FLYW</a>) from Overweight to Equal-Weight and lowers the price target from $26 to $15.

Downgrades

FLYW

Stephens & Co. Downgrades Flywire to Equal-Weight, Lowers Price Target to $15

Wells Fargo analyst Larry Biegelsen maintains Merit Medical Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MMSI#NASDAQ">MMSI</a>) with a Overweight and lowers the price target from $120 to $117.

MMSI

Wells Fargo Maintains Overweight on Merit Medical Systems, Lowers Price Target to $117

Salesforce shares are trading high. The stock may be moving in anticipation of the company's Q4 financial results, which it's scheduled to report after hours today.

With inflation still weighing on investors' minds, F/m Investments has<a href="https://www.benzinga.com/etfs"> launched a new ETF</a> designed to keep cash safe while offering inflation protection. 
The F/m Ultrashort Treasury Inflation-Protected Security ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBIL#NASDAQ">RBIL</a>) focuses exclusively on ultrashort-duration TIPS (Treasury Inflation-Protected Securities), which are bonds that adjust for inflation but mature in 13 months or less.
While inflation has cooled from its 2022 peak, it remains above the Federal Reserve's 2% target. Meanwhile, over $7 trillion sits in money market funds, and another $18 trillion in bank deposits, earning interest but offering little inflation protection. RBIL <a href="https://www.businesswire.com/news/home/20250224219690/en/Fm-Investments-Launches-Industry-First-Ultrashort-Treasury-Inflation-Protected-Security-TIPS-ETF-RBIL">provides </a>a lower-risk alternative for investors who want to maintain their purchasing power without having to bear the volatility of traditional inflation hedges like gold or real estate.
Also Read: <a href="https://www.benzinga.com/25/02/43922550/politics-meets-profit-defiance-etfs-files-for-mag7-themed-etf-magt">Defiance Seeks SEC Approval For ETF Tied To Trump Policies: &#8216;You Could Have A Nice Run, But&#8230;&#8217;</a>
Many existing TIPS ETFs carry longer durations, meaning their value can drop when interest rates rise. "As inflation spiked in 2021 and 2022, many investors saw their TIPS ETFs underperform because of their inherent duration," said Alex Morris, CEO of F/m Investments. "RBIL's ultrashort duration is designed to solve that problem."
In 2021, investors poured record funds into TIPS (Treasury Inflation-Protected Securities) ETFs. However, the rapid inflation spike and the Fed's aggressive rate hikes led to rising yields, causing TIPS prices to drop despite inflation adjustments, according to a report by the Financial Times. In 2022, Bloomberg's total return TIPS index fell nearly 12%, almost matching the 12.5% decline in a comparable US bond index, even as inflation hit 6.45%, the report said.
The ETF tracks the Bloomberg U.S. Ultrashort TIPS 1-13 Months Total Return Unhedged USD Index and has an expense ratio of 0.25%.
For investors looking to protect their cash from inflation without taking on big risks, RBIL could be the right tool at the right time. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/02/43924482/exclusive-3-etfs-positioned-for-microsofts-quantum-breakthrough">EXCLUSIVE: 3 ETFs Positioned For Microsoft&#8217;s Quantum Breakthrough</a></li>
</ul>
Photo: Shutterstock

New ETFs

ETFs

RBIL

New TIPS ETF Aims To Protect Cash As Inflation Stays Stubborn

<ul>
<li>Philips integrates advanced AI algorithms into its MRI systems, featuring Dual AI-driven engines in SmartSpeed Precise [1] to enable faster scanning</li>
<li>Innovations include the latest AI-enabled MR Workspace software to enhance patient throughput, reduce scan times, and improve image quality—leading to more accurate diagnoses, shorter wait times, and reduced backlogs for MRI scans</li>
<li>The latest technology is available across Philips' 1.5T and 3.0T MRI scanners [2], including the latest helium-free 1.5T high-performance BlueSeal wide-bore system [3,4], supporting healthcare providers worldwide</li>
</ul>
Amsterdam, The Netherlands and Vienna, Austria – <a href="https://www.globenewswire.com/Tracker?data=OKgd3pahs2OQXp2t4hkPVLl1U9rIS3SmOHkk6tyZsuLb8QFojiM4ij8_4XeGxDBlZbDWXNKTXLOUJc6NoVc3tMxnGuc5c_t9lXPMIJcbK4M=">Royal Philips</a> (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHG#NYSE">PHG</a>, AEX: PHIA))), a global leader in health technology, strengthens its MRI leadership with the launch of SmartSpeed Precise [1], powered by Dual-AI engines. Building on its award-winning [5] <a href="https://www.globenewswire.com/Tracker?data=IMPR-tHgOkNuf-q0b2iHzk38Vi3ewcMDTGkWtvtbSu79bOKVz-WOQlFgsmNaTpM80EZAq0drWfE0tqmDdqVCkJ3zNe9fZ92kSsGod3LGto9pBSSWldZ0RgCy3J-1MIlVY-ZbbYWpb4Oml7EJv-AeX81ohdFHVvdh-CUzt7qUSt7r-TozfvUBurefi0Qkkb_n">Compressed SENSE</a> and <a href="https://www.globenewswire.com/Tracker?data=65mXpke_iCjhmJhIaDGs3Bc-xo0_Ro_8mGPrEx6pWWW0KqYdUYjhy5gfdokUT3bWxu8BRhlnfQJbPMKxAaVi0Fei7rmQZaznwbC1AcH5mtUKCOIIJTX7d1hiETvsmVvzwCiZ5MWoR6zFY9xk-fvIzg==">SmartSpeed</a> technologies, this next-generation solution delivers faster scans with higher image quality. Debuting at the 2025 European Congress of Radiology (<a href="https://www.globenewswire.com/Tracker?data=sZzAy5ub4MbOdn7i70QxsPn8g9m6dkV1-4oqa0AbOWtt_46N-cOdZXW43vjSQFP1MgwvDEpv6SnX_py3NGZGG-uEvl_p50iZ-d5G3lTEDH0=">ECR 2025</a>, Feb. 26-Mar. 2, Vienna, Austria), SmartSpeed Precise significantly improves scan speed and diagnostic image quality, extending AI-driven efficiency across the entire <a href="https://www.globenewswire.com/Tracker?data=y3CI4tgtz6u9YhKgvbCYmA8ErlMo7FbBbbqQjm_tUWJgyke2WspHRo1o7ARm42K9NrpO7bwViqGGXRQoJLFRV4sU3M_i7eY6iF4sPymA-CS-RKr3uCTdhJ3GH1Gxle30eyUtf6qyYNRqSLt5WGe5Dw==">Philips MR portfolio</a>—including existing customer systems. Also showcased will be the latest MR Workspace software release 12 [6], which streamlines workflows and empowering clinicians to deliver faster, more accurate diagnoses. These innovations reflect Philips' commitment to enhancing efficiency, accessibility, and precision in MR imaging. &nbsp;

Philips Integrates Advanced AI Into MRI Systems With Dual AI Engines For Faster Scanning, Enhanced Image Quality, And Reduced Wait Times; Innovations Include Helium-Free 1.5T BlueSeal Wide-Bore System

VTEX

VTEX shares are trading lower after the company reported worse-than-expected Q4 financial results.

Wells Fargo analyst Stan Berenshteyn maintains HealthEquity (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HQY#NASDAQ">HQY</a>) with a Overweight and raises the price target from $110 to $125.

Wells Fargo Maintains Overweight on HealthEquity, Raises Price Target to $125

Super Micro Computer Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMCI#NASDAQ">SMCI</a>) just dodged a major bullet, and <a href="https://www.benzinga.com/quote/SMCI/news">Wall Street is cheering</a>. 
The artificial intelligence-focused server maker skyrocketed over 26% in premarket trading on Wednesday after announcing it had regained compliance with Nasdaq's filing requirements. 
But while the delisting threat is off the table, technical signals suggest the rally might not be smooth sailing.
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022625&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="622" height="488" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/26080909/Screenshot-2025-02-26-at-6.38.46-PM.png" alt="" class="wp-image-799469" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/26080909/Screenshot-2025-02-26-at-6.38.46-PM.png 622w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/26080909/Screenshot-2025-02-26-at-6.38.46-PM-300x235.png 300w" sizes="(max-width: 622px) 100vw, 622px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022625&amp;t=be2bearmibe3na1" target="_blank" rel="noreferrer noopener">Chart created using Benzinga Pro</a>
<h2 class="wp-block-heading">SMCI Stock Moderately Bullish, But Selling Pressure Spells Caution</h2>
SMCI's stock has been on a wild ride, up 51.55% year to date but dropping 22.64% over the past five days. While the current trend remains moderately bullish, selling pressure is creeping in, raising concerns about a potential bearish shift.
Technically, the eight-day simple moving average of $50.28 and the 200-day simple moving average of $52.75 suggest resistance ahead, reinforcing the risk of a pullback. However, support remains strong, with the 20-day simple moving average at $41.88 and the 50-day simple moving average at $36.24, both flashing bullish signals.
Meanwhile, the Moving Average Convergence Divergence (MACD) indicator of 5.80 leans bullish, but with a Relative Strength Index of 63.50, SMCI stock looks heated. Any movements closer to the 70 (overbought) mark could trigger a pullback.
<h2 class="wp-block-heading">Dodging Nasdaq's Ax</h2>
Super Micro <a href="https://ir.supermicro.com/news/news-details/2025/Supermicro-Files-Form-10-K-for-Fiscal-2024-and-Forms-10-Q-for-the-First-and-Second-Quarters-of-Fiscal-2025/default.aspx">submitted</a> its long-delayed financial results for fiscal 2024 and the first half of fiscal 2025 to the U.S. Securities and Exchange Commission, securing the green light from Nasdaq. The company had been under pressure after losing its previous auditor, Ernst &amp; Young, and uncovering weaknesses in internal controls. While the fresh audit from BDO confirmed the company's numbers, it also flagged governance issues—something investors should not ignore.
Related: <a href="https://www.benzinga.com/25/02/43967143/smci-stock-surges-over-26-in-wednesday-pre-market-whats-going-on">SMCI Stock Pops Over 26% In Wednesday Pre-Market After Super Micro Computer Says It &#8216;Regained Compliance&#8217;</a>
Despite the turbulence, Super Micro's business remains on fire. Fueled by surging demand for Nvidia Corp's (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) graphics processing units, the company's sales more than doubled to $14.99 billion in fiscal 2024. Elon Musk's artificial intelligence venture, xAI, is among its high-profile customers.
<h2 class="wp-block-heading">What's Next For SMCI Stock?</h2>
With Nasdaq compliance secured, Super Micro has removed a key overhang, but questions remain about governance risks and potential litigation. 
SMCI stock's sharp premarket move shows investor relief, but whether it can sustain gains depends on market confidence in its long-term fundamentals. 
Traders should watch for a break above resistance levels to confirm continued bullish momentum—or signs of selling pressure dragging the stock lower.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/government/regulations/25/02/43967649/us-stocks-likely-to-open-higher-ahead-of-nvidia-earnings-sp-500s-four-day-fall-was-a-non-event-says-expert">US Stocks Likely To Open Higher Ahead Of Nvidia Earnings: S&amp;P 500&#8217;s Four-Day Fall Was A &#8216;Non-Event,&#8217; Says Expert</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Technicals

NVDA

SMCI

Super Micro Stock Soars On Nasdaq Compliance, But Can The Rally Hold?

MGPI

MGP Ingredients shares are trading lower after the company issued FY25 EPS guidance below estimates.

Wells Fargo analyst Elyse Greenspan maintains Baldwin Insurance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BWIN#NASDAQ">BWIN</a>) with a Underweight and lowers the price target from $38 to $33.

BWIN

Wells Fargo Maintains Underweight on Baldwin Insurance, Lowers Price Target to $33

Ana Robic appointed Regional President, Europe, Middle East and Africa, succeeding David Furby who is named Executive Chairman
Melissa Scheffler promoted to succeed Robic as Division President, Personal Risk Services, Chubb North America Insurance
ZURICH, Feb. 26, 2025 /PRNewswire/ -- Chubb Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CB#NYSE">CB</a>) today announced that Ana Robic, Senior Vice President, Chubb Group and currently Division President of Personal Risk Services (PRS), Chubb North America, has been appointed Regional President of Europe, Middle East and Africa. She succeeds David Furby, Senior Vice President, Chubb Group, who has been named Executive Chairman of Europe, Middle East and Africa.

Management

Global

Chubb Announces Ana Robic As New Regional PresidentFor Europe, Middle East, and Africa; David Furby Appointed Executive Chairman For The Region

Safe And Green Development Announces Acquisition Of Resource Group US Holdings For $480K Cash, 19% SGD Restricted Stock, Convertible Note; Total 49% SGD Shares At Closing, Terms Include Shareholder Approval, Deal Closes Q2 2025

Wells Fargo analyst Roger Read maintains Delek US Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DK#NYSE">DK</a>) with a Underweight and lowers the price target from $17 to $15.

Wells Fargo Maintains Underweight on Delek US Hldgs, Lowers Price Target to $15

ELC will step-change innovation by translating innovative anti-inflammation research into cutting-edge skin care solutions
The Estée Lauder Companies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EL#NYSE">EL</a>) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in cosmetics to deliver significant skin care longevity benefits to consumers around the world.
The exclusive partnership will accelerate ELC's focus on transformative product innovation by applying insights from Serpin Pharma's two decades of anti-inflammatory research, which has yielded proprietary biotech technology demonstrating remarkable efficacy mitigating harmful inflammation and enhancing cell resiliency. Serpin Pharma identified a key portion of a superfamily of proteins called SERPINs (Serine Protease Inhibitors) that enhance the body's natural ability to heal cells experiencing inflammation. Together, the companies are investigating how this innovative technology, which leverages the body's innate immune response, can be harnessed to address skin irritation, aging, and sensitivity. Scientific studies are underway to demonstrate how Serpin's technology can be applied to cosmetic products to rapidly and visibly reduce skin aging and irritation.

Estée Lauder Announces Collaboration With Serpin Pharma To Explore Anti-Inflammatory Research For Skin Care Innovations

Wells Fargo analyst Neil Kalton maintains Public Service Enterprise (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PEG#NYSE">PEG</a>) with a Overweight and lowers the price target from $100 to $95.

Wells Fargo Maintains Overweight on Public Service Enterprise, Lowers Price Target to $95

PBPB

Potbelly Sandwich Works Expands Its Locations To Texas, St. Louis, Lake Charles, LA, Virginia Beach And Norfolk

골드만삭스 애널리스트 카쉬 랑간(Kash Rangan)은 몽고DB(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDB#NASDAQ">MDB</a>)의 보이지AI(Voyage AI) 인수에 대해 월요일(24일) <a href="https://www.benzinga.com/quote/mdb/analyst-ratings" target="_blank" rel="noopener">매수 의견과 목표주가를 유지</a>했다.
몽고DB는 블룸버그에 현금 및 주식 거래로 2억 2천만 달러에 <a href="https://www.benzinga.com/media/25/02/43916988/mongodb-expands-ai-capabilities-with-voyage-ai-deal-targets-faster-insights-from-unstructured-data" target="_blank" rel="noopener">보이지AI를 인수</a>했다고 밝혔다.
카쉬 랑간은 보이지AI 인수가 몽고DB의 AI 제품 로드맵과 현대적인 데이터 스택 내에서의 위치를 강화할 것이라고 믿고 있다고 말했다. 이는 주로 보이지의 고급 텍스트 임베딩 및 재랭킹 모델 덕분인데, 이 모델은 조직의 RAG 지원 AI 애플리케이션을 더 나은 문맥적 관련성, 비용 효율성, 지연 시간 감소와 함께 만들 수 있는 능력을 향상시킨다.
또한 애널리스트는 보이지AI에 따르면 보이지의 주력 제품인 범용 다국어 임베딩 모델 &#8216;voyage-3-large'(2025년 1월 7일 출시)가 검색 품질 면에서 &#8216;오픈AI-v3-large&#8217;와 &#8216;Cohere-v3-English&#8217;를 각각 평균 9.74%와 20.71%씩 능가한다고 언급했다.
그리고 보이지AI의 voyage-3-large는 양자화 인식 훈련과 마트료시카 학습과 같은 고급 기술을 사용하여 검색 품질에 미치는 영향을 최소화하면서 저장 비용과 처리 시간을 줄이는 새로운 정확도-비용 기준을 설정한다고 강조했다.
그는 전반적으로 보이지AI 인수를 몽고DB의 기술과 인재 확보를 위한 가치 있는 투자로 보고 있으며, 보이지의 모델(올해 말 통합 예정)은 성능과 비용상의 이점을 제공하는 최상위 임베딩 모델을 제공하여 몽고DB 플랫폼에서 AI 생산 워크로드를 빠르게 추적할 수 있는 잠재력을 가지고 있다고 평가했다.
이러한 부분은 랑간이 예측한 중장기 매출 성장률 20% 이상과 일치한다.
현재 매출의 약 70%를 차지하고 있으며, 출시 이후 20% 이상 꾸준히 성장하고 있는 아틀라스(Atlas)의 경우, 중기적으로 지속적인 성장 가능성이 높고, 장기적으로는 60억~80억 달러 이상의 매출을 달성할 수 있을 것으로 보고 있다.
투자자들은 TrueShares Technology, AI &amp; Deep Learning ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRNZ#NYSE">LRNZ</a>) 및 Sterling Capital Focus Equity ETF(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LCG#NYSE">LCG</a>)를 통해 몽고DB 주식에 대한 노출을 얻을 수 있다.
주가 움직임: 몽고DB 주가는 화요일에 2.77% 하락한 259.71달러에 마감했다.
사진: Shutterstock
다른 트레이더들보다 30분 일찍 시장 움직임에 대한 독점 뉴스를 받아보세요.
Benzinga Pro의 독점 뉴스를 통해 수백만 명의 다른 트레이더보다 더 빠르게 유용한 투자 뉴스를 확인할 수 있습니다. <a href="https://www.benzinga.com/pro/register?t=be2bewe5mibe3bz3&amp;utm_source=bz-kor">여기를 클릭</a>하여 14일 무료 체험을 시작하세요.

골드만삭스: 몽고DB의 '보이지 AI' 인수, 고급 기술과 인재로 AI 능력 향상

Comments

TrueShares Technology, AI & Deep Learning ETF

뉴스

에 대한 최신 뉴스 TrueShares Technology, AI & Deep Learning ETF (ARCA:LRNZ)

수요일, 2월 26, 2025

뉴스

파트너 / 기고자

벤징가 글로벌